Introduction Non–small cell lung cancer (NSCLC) is often diagnosed at later stages when
treatment options are limited. Maintenance therapy may prolong the time to disease …

Although well established for the treatment of certain hematologic malignancies,
maintenance therapy has only recently become a treatment paradigm for advanced non …

Maintenance therapy refers to the use of an active therapeutic agent for extended duration
following frontline induction therapy for patients with advanced stage non-small cell lung …

Lung cancer is the most common cancer worldwide with non-small cell lung cancer
(NSCLC), including squamous carcinoma, adenocarcinoma and large cell carcinoma …

Maintenance therapy for patients with advanced non-small cell lung cancer has been an
area of intense investigation. Maintenance therapy has been divided into two broad …

Systemic chemotherapy with platinum‐based regimens provides modest improvements in
survival and quality of life for patients with advanced‐stage nonsmall‐cell lung cancer …

Maintenance chemotherapy has a long history of use in hematologic malignancies, in which
the benefits are considerable in terms of survival and quality of life. Recently, several studies …